Mani, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3869920003
JPY
1,524.00
3 (0.2%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

378.7 k

Shareholding (Aug 2024)

FII

0.02%

Held by 1 FIIs

DII

99.98%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Weak Long Term Fundamental Strength with a 15.78% CAGR growth in Net Sales over the last 5 years

 
2

Poor long term growth as Net Sales has grown by an annual rate of 15.78% over the last 5 years

 
3

Flat results in May 26

4

With ROE of 10.62%, it has a expensive valuation with a 3.14 Price to Book Value

5

Underperformed the market in the last 1 year

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

JPY 166,925 Million (Small Cap)

stock-summary
P/E

30.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.41

stock-summary
Return on Equity

11.27%

stock-summary
Price to Book

2.92

Revenue and Profits:
Net Sales:
8,290 Million
(Quarterly Results - May 2026)
Net Profit:
1,744 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.69%
0%
-8.69%
6 Months
-2.93%
0%
-2.93%
1 Year
17.82%
0%
17.82%
2 Years
-20.67%
0%
-20.67%
3 Years
-18.42%
0%
-18.42%
4 Years
-7.19%
0%
-7.19%
5 Years
-34.03%
0%
-34.03%

Mani, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
15.78%
EBIT Growth (5y)
16.64%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.33
Sales to Capital Employed (avg)
0.55
Tax Ratio
33.85%
Dividend Payout Ratio
82.74%
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
27.23%
ROE (avg)
11.30%

Valuation key factors

Factor
Value
P/E Ratio
30
Industry P/E
Price to Book Value
3.14
EV to EBIT
16.99
EV to EBITDA
13.34
EV to Capital Employed
4.58
EV to Sales
4.96
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
26.94%
ROE (Latest)
10.62%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Aug 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.02%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - May'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "May'26",
        "Nov'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8,290.00",
          "val2": "7,828.00",
          "chgp": "5.90%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3,002.00",
          "val2": "2,862.00",
          "chgp": "4.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "16.00",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,744.00",
          "val2": "1,896.00",
          "chgp": "-8.02%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "288.20%",
          "val2": "288.10%",
          "chgp": "0.01%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Aug'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Aug 2025 is 5.10% vs 16.44% in Aug 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Aug 2025 is -26.14% vs 5.59% in Aug 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Aug'25",
        "Aug'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "29,968.00",
          "val2": "28,513.00",
          "chgp": "5.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "10,665.00",
          "val2": "10,662.00",
          "chgp": "0.03%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.00",
          "val2": "6.00",
          "chgp": "-50.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1,175.00",
          "val2": "-70.00",
          "chgp": "-1,578.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4,643.00",
          "val2": "6,286.00",
          "chgp": "-26.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "273.40%",
          "val2": "294.30%",
          "chgp": "-2.09%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - May'26 - QoQstock-summary

May'26
Nov'25
Change(%)
Net Sales
8,290.00
7,828.00
5.90%
Operating Profit (PBDIT) excl Other Income
3,002.00
2,862.00
4.89%
Interest
0.00
0.00
Exceptional Items
0.00
16.00
-100.00%
Consolidate Net Profit
1,744.00
1,896.00
-8.02%
Operating Profit Margin (Excl OI)
288.20%
288.10%
0.01%
USD in Million.
Net Sales

Not Applicable: The company has declared_date for only one period

Consolidated Net Profit

Not Applicable: The company has declared_date for only one period

Annual Results Snapshot (Consolidated) - Aug'25stock-summary

Aug'25
Aug'24
Change(%)
Net Sales
29,968.00
28,513.00
5.10%
Operating Profit (PBDIT) excl Other Income
10,665.00
10,662.00
0.03%
Interest
3.00
6.00
-50.00%
Exceptional Items
-1,175.00
-70.00
-1,578.57%
Consolidate Net Profit
4,643.00
6,286.00
-26.14%
Operating Profit Margin (Excl OI)
273.40%
294.30%
-2.09%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Aug 2025 is 5.10% vs 16.44% in Aug 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Aug 2025 is -26.14% vs 5.59% in Aug 2024

stock-summaryCompany CV
About Mani, Inc. stock-summary
stock-summary
Mani, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available